Category: Featured

  • FDA Publishes List of Marketing Applications

    FDA Publishes List of Marketing Applications

    Photo: alotofpeople

    The U.S. Food and Drug Administration’s Center for Tobacco Products has introduced a new webpage on its site entitled “Deemed New Tobacco Product Application Lists.” The webpage lists and features 17 MS Excel files that include over 6 million deemed new tobacco products for which a premarket application was submitted to the FDA by Sept. 9, 2020.

    A court order provided for a one-year period during which time such products might remain on the market pending FDA review. If a negative action is taken by the FDA on the application prior to Sept. 9, 2021, the product must be removed from the market or risk FDA enforcement. If a positive order is issued by the FDA on a product in the below lists, the product will be listed on the positive marketing orders page and may continue to be marketed according to the terms specified in the order letter.

    The FDA stressed it has not independently verified the information provided by applicants about the marketing status of their products. In addition, the list excludes entries of products from companies that did not provide information on current marketing status of their products to the FDA so that the agency could determine whether the existence of the application could be disclosed. 

    “It is important to note that the lists are not comprehensive lists intended to cover all currently marketed deemed tobacco products that a company generally might manufacture, distribute or sell without risking FDA enforcement,” the FDA wrote on its website.

    Companies that submitted their application by the Sept. 9, 2020, deadline can keep their products on the market for one year pending FDA review.

    If a negative action is taken by the FDA on the application prior to Sept. 9, 2021, the product must be removed from the market or risk FDA enforcement. If a positive order is issued by the FDA on a product in the lists, the product will be listed on the positive marketing orders page and may continue to be marketed according to the terms specified in the order letter.

    The publication of the list likely signals the start of enforcement. The FDA has already issued 111 warning letters to vapor companies in 2021.

    Stakeholders in the nicotine business have been anticipating the FDA list for months. In September 2020, the FDA stated that it would publish a list of vapor companies that had submitted PMTAs by the Sept. 9, 2020, deadline. The news came just one week after several retail groups submitted a letter to the agency asking for a published list of applicants.

  • WHO Reiterates its Opposition to THR

    WHO Reiterates its Opposition to THR

    Photo: Olrat

    In the runup to World No Tobacco Day on May 31, the World Health Organization (WHO) has reasserted its abstinence-only approach to nicotine.

    In a May 19 press release titled “Quit tobacco to be a winner,” the WHO said that the tobacco industry has “promoted e-cigarettes as cessation aids under the guises of contributing to global tobacco control” while employing “strategic marketing tactics to hook children on this same portfolio of products, making them available in over 15,000 attractive flavors.”

    The agency also insisted that the scientific evidence on e-cigarettes as cessation aids was inconclusive and that “switching from conventional tobacco products to e-cigarettes is not quitting.”

    “We must be guided by science and evidence, not the marketing campaigns of the tobacco industry—the same industry that has engaged in decades of lies and deceit to sell products that have killed hundreds of millions of people,” said WHO Director-General Tedros Adhanom Ghebreyesus. “E-cigarettes generate toxic chemicals, which have been linked to harmful health effects, such as cardiovascular disease and lung disorders.”

    We must be guided by science and evidence, not the marketing campaigns of the tobacco industry.

    The global health body also reiterated its commitment to excluding the tobacco industry from the debate through article 5.3 of the Framework Convention on Tobacco Control.

    “The tobacco industry is the single greatest barrier to reducing deaths caused by tobacco use,” the WHO wrote. “Their interests are irreconcilably opposed to promoting public health and point to a critical need to keep them out of global tobacco control efforts.”

    The organization also cited the United Nations Global Compact, which banned the tobacco industry from participation in 2017. “In line with Article 5.3, industry has been entirely excluded from the U.N. system, and its agencies have been urged to devise strategies to prevent industry interference,” the WHO wrote.

  • Blind Test: Smokers Unable to Detect Brands

    Blind Test: Smokers Unable to Detect Brands

    Photo: fotofabrika

    When properly blinded, smokers are unable to tell apart brands of cigarettes, according to a study by the Sharik Association for Health Research and Alfaisal University in Saudi Arabia that was published in JMIR Formative Research.

    In 2019, Saudi Arabia implemented a law requiring cigarette manufacturers to sell their products in generic, unbranded packaging. Following the measure, smokers started complaining to the Saudi Food and Drug Authority (SFDA) about a perceived difference in cigarette quality. These complaints persisted for more than 90 days, starting in mid-November 2019 and continuing until at least March 2020, when the researchers started writing their manuscript.

    Tobacco companies denied changing ingredients, manufacturing processes and the quality of tobacco sold in Saudi Arabia.

    Smokers in the United Kingdom and Australia also complained about taste differences after their countries implemented plain tobacco packaging.

    Previous studies of the matter did not find significant differences in taste, but they highlighted the difficulties of measuring this variable, which may affect the results. The main difficulty is in the method of measuring the difference between the branded and the plain-packaged cigarettes without exposing participants to the brand they are trying during the study. No previous study was fully able to blind the participants to the cigarette branding, although the senses are known to affect the taste.

    Remarkably, no significant differences were seen in smokers’ ability to identify their favorite brands.

    For the current study, researchers fitted each participant with virtual reality goggles accompanied by special software to alter the visual reality. In addition, the participants wore medical gloves to alter the feeling of touching the cigarettes. Then, participants received six sequences of different random exposures (three puffs) to three plain-packaged cigarettes (two from their favorite brand and one from another brand as a control) and three branded cigarettes (two from the favorite brand and one from another brand as a control).

    After controlling participants’ visual and touch perceptions, no significant differences were observed in their ability to identify plain versus branded cigarettes. Remarkably, no significant differences were seen in smokers’ ability to identify their favorite brands.

    The experiment convinced participating smokers that the taste of cigarettes in Saudi Arabia remained unchanged after plain packaging. Prior to the experiment, 16 out of 18 participants thought they detected a change compared to the old, branded cigarettes. After the experiment, all participants reported that they had changed their opinion and did not believe any taste differences existed between plain-packaged and branded cigarettes.

    The authors note that sensory perception and sensory research are priorities within the tobacco industry because they have direct effects on commercial concerns. Sensory aspects contribute to smoker satisfaction and tobacco product acceptance, and they play an important role in controlling cigarette-puffing behavior. According to the researchers, tobacco companies have capitalized on distinct sensory preferences across gender, age and ethnic groups by tailoring products for specific populations.

  • Taat to Stand Out Among U.K. Plain Packs

    Taat to Stand Out Among U.K. Plain Packs

    Taat Global Alternatives has developed the pack designs for Taat Original, Smooth and Menthol for sale at retail in the United Kingdom.

    Packaging for all tobacco cigarettes in the United Kingdom must adhere to requirements, including a designated principal color, a smooth surface with no texture or embossing and the absence of promotional images or logos. Because Taat is a nontobacco product, it is subject to different packaging regulations. The company expects its brightly colored packages to stand out compared to the plain packaging of traditional cigarettes.

    Taat CEO Setti Coscarella

    Anytime your product is visually outstanding from its competition, a lot of work is already done for you.

    “We are very excited about our impending entrance into the U.K. market and our advantageous product distinction on the shelf. Anytime your product is visually outstanding from its competition, a lot of work is already done for you,” said Setti Coscarella, CEO of Taat, in a statement.

    “As we continue to explore opportunities outside of the U.K., we recognize that the European Union presents a complicated regulatory network, with each member country implementing its own rules with respect to importation, packaging tariffs and other factors. Interest in our product from legal-aged smokers in Europe has been overwhelming, and we will navigate the regulations on a country-by-country basis.”

  • Bates: Juul Publication Complaints Absurd

    Bates: Juul Publication Complaints Absurd

    Clive Bates

    Recent complaints about The American Journal of Health BehaviorSpecial Issue on Juul” are absurd, anti-scientific and somewhat disturbing, according to Clive Bates, director of The Counterfactual.

    In a letter to the editor, Bates said the Juul Labs monograph provides highly salient information on changes in smoking status, drivers of transition, population health impact and retailer behaviors. “The summary for the introduction to the series should be enough to whet the appetite of the genuinely curious and scientifically engaged,” he wrote.

    According to Bates, the fact that research is done by a company in the nicotine-delivery business does not invalidate the findings. In his view, Juul’s scientists have done excellent work that stands on its merits and has now been published after thorough peer review in a reputable journal with transparent disclosure of its provenance.

    “The real question here is why these tobacco control activists show so little curiosity about the changes that are reshaping the U.S. tobacco and nicotine market,” he wrote. “As Juul rose in popularity, we saw unusually rapid declines in cigarette sales and smoking prevalence in both adults and adolescents.

    “The right response to that is to want to know more. The wrong response is to try to suppress or discredit informative data and analysis just because it tells a story that is at variance with a narrative about the evils of both e-cigarettes and the companies that make them.”

  • Imperial Brands Named Climate Leader

    Imperial Brands Named Climate Leader

    Photo: Casimirokt | Dreamstime.com

    Imperial Brands has been recognized as a 2021 Climate Leader by the Financial Times in its first-ever ranking of actions taken by European businesses.

    The Financial Times’ listing identifies the 300 companies across the continent that achieved the highest reduction in core greenhouse gas emissions between 2014 and 2019.

    Imperial is committed to further reducing its carbon footprint. By 2030, from a base year of 2017, the business will cut its own greenhouse emissions by 25 percent and emissions in its supply chain by 20 percent.

    “We are pleased to be highlighted by the Financial Times for our efforts to reduce our impact on the climate,” said Stefan Bomhard, CEO of Imperial, in a statement. “There’s more we need to achieve to address this critical issue, but the recognition we’ve received demonstrates that we’re heading in the right direction.”

    In late 2020, Imperial maintained its position on the CDP’s “A List” for climate change. CDP’s annual environmental disclosure and scoring process recognizes corporate leaders in climate transparency and action.

  • PMI Reports Progress Toward ‘End of Smoking’

    PMI Reports Progress Toward ‘End of Smoking’

    Photo: krsmanovic

    Philip Morris International on May 18 published its Integrated Report, a comprehensive overview of the company’s environmental, social and governance (ESG) performance and its progress toward its purpose of delivering a smoke-free future.

    This includes its 2025 ambitions to have switched more than 40 million adult smokers to its smoke-free products, with half from non-OECD countries, and for smoke-free products to account for more than 50 percent of PMI’s total net revenues.

    Further accelerating PMI’s transformation, this year, the company introduced two new 2025 ambitions linked to its business transformation metrics: for its smoke-free products to be available in 100 markets and for at least $1 billion in annual net revenues to come from “beyond nicotine” products. The Integrated Report also outlines case studies of early indications of PMI’s smoke-free products’ impacts in markets where such products have a meaningful presence.

    “I present this report with pride in what we have already achieved in just five years, such as smoke-free products accounting for nearly one-quarter of our total net revenues in 2020 from essentially zero in 2015. I also have a deep recognition of the immense work ahead. Our new ambitious goals signal our confidence in our ability to monumentally change our company’s long-term future,” said Jacek Olczak, chief executive officer, in a statement.

    I present this report with pride in what we have already achieved in just five years, such as smoke-free products accounting for nearly one-quarter of our total net revenues in 2020.

    “PMI is committed to serving as an agent of change and advocate of positive values. Innovation and inclusiveness are key to solving our challenges, whether related to tobacco harm reduction, environmental impact or social impact. We aim to create a sustainable future that benefits our company, shareholders, consumers and society.”

    PMI’s Integrated Report 2020 demonstrates how the organization’s strategy, governance and performance create value. To showcase impact, the company reports on progress in various ESG areas, including toward achieving its ambitious 2025 Roadmap—a set of forward-looking targets pertaining to all Tier 1 topics from PMI’s sustainability materiality assessment.

    The report highlights PMI’s most material sustainability topics, including the health impacts of its products—an aspect often not captured by external ESG assessments—and describes how the company is working toward researching, developing and commercializing scientifically substantiated better alternatives to continued smoking for those adults who do not quit. It also includes a new section on the company’s business transformation—which extends beyond changing the product—and an update on its business transformation metrics (BTMs).

    The company’s BTMs are a set of bespoke key performance indicators introduced in 2016 to complement its ESG disclosure. These metrics allow stakeholders to transparently assess both the pace and scale of PMI’s transformation. Since then, based on stakeholder feedback, PMI has expanded the number of metrics to 28, with three new metrics introduced in this report.

    The report also outlines the company’s belief that sustainability strategy is corporate strategy and that ESG issues are business issues. Reflecting this commitment to sustainability, the global sustainability team is now part of the finance function, reporting directly to the chief financial officer. In addition, executive compensation is now more clearly linked to ESG performance, complementing the strong product transformation incentives already in place.

    “Sustainability stands at the core of PMI’s transformation and drives our development of strong ESG programs to mitigate the risks associated with our value chain while spurring innovation and growth to secure our success over the long term,” said Emmanuel Babeau, chief financial officer. “It is our firm belief that sustainability and corporate performance do not follow separate paths, and I am proud that we have spent the last year continuing to strengthen our sustainability governance and ensuring that ESG is integrated into decision-making at all levels of our organization.”

    I am proud that we have spent the last year continuing to strengthen our sustainability governance and ensuring that ESG is integrated into decision-making at all levels of our organization.

    Acknowledging the unique and difficult challenges of the past year, PMI dedicated sections throughout its Integrated Report to showing how it addressed the impacts of the Covid-19 pandemic on its workers, business and value chain as well as instances where the pandemic directly affected the company’s sustainability efforts and the adjustments made in response.

    “Despite the unprecedented challenges brought on by the global pandemic, we have not deviated from our efforts to show care, support those in our orbit and continue our quest to become a more sustainable company,” said Jennifer Motles, chief sustainability officer. “As we continue to transform, stakeholder engagement and constructive dialogue remain paramount to this evolution. In 2020, multi-stakeholder partnerships were key to the significant progress we made toward addressing many of our priority sustainability topics, ranging from protecting the health and safety of our employees to safeguarding the human rights of those impacted by our business and accelerating efforts to mitigate our impact on climate change throughout our value chain.”

    The report was prepared following the Integrated Reporting framework and is in accordance with the Global Reporting Initiative Standards (core option).

    It aligns with the principles and standards of the U.N. Global Compact and indicates contributions to the U.N. Sustainable Development Goals and corresponding targets.

    PMI’s Integrated Report addresses some recommendations of the Task Force on Climate-related Financial Disclosures, with its environmental reporting to CDP covering most of the remainder.

    Despite the unprecedented challenges brought on by the global pandemic, we have not deviated from our efforts to show care, support those in our orbit and continue our quest to become a more sustainable company.

    It also considers guidance from the Sustainability Accounting Standards Board (SASB). Furthermore, for the first time—and as a result of PMI’s business transformation—it cross-references most aspects of the SASB standards defined for technology and communications, more concretely the Hardware Standard, and it also describes alignment with some aspects of the standards developed for the healthcare industry, specifically the medical equipment and supplies standard.

    Finally, the content of PMI’s Integrated Report 2020 is mapped against the 21 metrics defined by the International Business Council/World Economic Forum’s “Measuring Stakeholder Capitalism: Toward Common Metrics and Consistent Reporting of Sustainable Value Creation” white paper to further reflect the importance of stakeholders, as per PMI’s statement of purpose.

    On June 2, PMI will host an ESG-focused webcast during which the company will offer additional insight into how integrating sustainability across its business creates value for its shareholders and stakeholders. PMI will also publish in the coming week an ESG Highlights document, which will provide a more data-focused executive summary of the Integrated Report and will be made available on PMI.com/investor-relations.

    Stakeholders can download the full Integrated Report 2020 as well as indexes mapping the company’s disclosures to internationally recognized frameworks on PMI.com/sustainability, including details about the company’s 16 Tier 2 sustainability topics.

  • Netherlands Pressed to Restrict ENDS

    Netherlands Pressed to Restrict ENDS

    Photo: vichie81

    Anti-smoking groups and pharmaceutical company Pfizer are urging the next Dutch government to extend smoking bans and restrict tobacco alternatives such as e-cigarettes, reports Dutch News.

    The outgoing government has increased cigarette prices and limited sales outlets as steps toward a smoke-free generation by 2040, and the number of smokers has gone down from 25 percent to 20 percent in the last five years.

    However, even though there are fewer smokers, the total amount of tobacco being consumed has remained stable. “The remaining smokers are smoking more,” campaigner Wanda de Kanter told Financieele Dagblad.

    De Kanter is skeptical about Philip Morris International’s attempts to market its IQOS tobacco-heating device as a less risky alternative to smoking. The multinational is trying to persuade the Dutch government to relax rules around such products. Health institute RIVM has stated that heated-tobacco still contains cancer-causing substances and can damage lung cells.

    I am concerned about these reports, especially in light of the global World Health Organization’s COP9 summit, which takes place in the Netherlands in November 2021.

    The U.K. Vaping Industry Association (UKVIA) warned that cracking down on smoking alternatives would be counterproductive.

    “To further reduce smoking rates in the Netherlands, legislators should be embracing alternative tobacco products, such as vaping—not introducing stricter regulations, which will only serve to facilitate tobacco consumption,” the group wrote in a press note. “Adopting an evidence-based approach, like that which has been successful in the United Kingdom, will help cement the concept of tobacco harm reduction.”

    “I am concerned about these reports, especially in light of the global World Health Organization’s COP9 summit, which takes place in the Netherlands in November 2021,” said UKVIA Director-General John Dunne.

    “Smoking-related illness still kills many thousands of people each year in both the U.K. and the Netherlands. It is imperative on both governments to do all that they can to reduce this number of smoking-related deaths. They should trust the science and the overwhelming evidence and embrace vaping products and e-cigarettes. They are the most popular and effective nicotine-replacement products on the market.”

  • KT&G Volume Surges by Nearly One-Third

    KT&G Volume Surges by Nearly One-Third

    Photo: KT&G

    KT&G’s sales surged 30.1 percent to 9.5 billion cigarettes in 2020, reports The Korea Times, citing recently released regulatory filings. In terms of value, the company’s sales rose 15.8 percent year-on-year to KRW193.7 billion ($171.68 million).

    KT&G attributed the performance to its expansion into new markets as well as customized strategies for different regions.

    Last year alone, KT&G launched its products in 23 new markets with the total number of export countries exceeding 100.

    In South Korea, KT&G sales rose by 60 million cigarettes from the previous year. Boosted by product launches such as “88 Returns,” the company’s domestic market share rose 0.6 percent to 64.5 percent—a remarkable accomplishment at a time when the Korean cigarette market shrunk by 0.1 percent.

    In the vapor segment, KT&G posted growth too. The company’s Lil tobacco-heating product accounted for more than a 60 percent market share at convenience stores in October.

    Starting this year, the company intends to enter new markets. In the first quarter of 2020, KT&G signed a strategic partnership with PMI to cooperate in exporting Lil while introducing the product in Russia, Ukraine and Japan, where it gained positive feedback.

  • Request to Drop Malawi Exploitation Case

    Request to Drop Malawi Exploitation Case

    Photo: AA+W

    British American Tobacco (BAT) and Imperial Brands will ask the high court in London on Wednesday to throw out a case against them alleging the exploitation of Malawian farmers and their children, reports The Guardian.

    Denying the allegations, the companies are asking that the case be dismissed on the grounds that lawyers for the farming families cannot prove the tobacco they grew ended up in their cigarettes and other products.

    “BAT believes that there is no legal or factual basis to bring these claims, therefore BAT has made an application for the claims to be struck out or stayed,” a BAT spokesperson told The Guardian.

    The case was brought after investigations by The Guardian suggested the companies employed child labor and subjected farmers to poor working conditions.

    Leigh Day lawyers argue that the farmers’ conditions of work breach the definition of forced labor, unlawful compulsory labor and exploitation under Malawian law.

    They also say that they breach the U.K. Modern Slavery Act, article 14 of the European convention on human rights and the International Labor Organization definition of forced labor.

    The heart of the claim is that two of the largest tobacco companies cynically exploited impoverished tobacco farmers from Malawi and their children.

    “The heart of the claim is that two of the largest tobacco companies in the world cynically exploited impoverished tobacco farmers from Malawi and their children,” said Martyn Day, senior partner at Leigh Day.

    “Fortunately, the two defendant companies are based here in Britain, giving our courts jurisdiction to adjudicate these claims.” He said he was optimistic the judge would allow the claims to progress toward a full trial.

    Several thousand of Malawi’s poorest tobacco tenant farmers have joined the claim. They sell their crop to a leaf-buying company in Malawi, which they say supplies BAT and Imperial.